ELVN•benzinga•
HC Wainwright & Co. Maintains Buy on Enliven Therapeutics, Raises Price Target to $39
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 21, 2025 by benzinga